Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Deblois

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Cancer Research|April 15, 1988
A comparison of the cardiopulmonary effects of continuous versus bolus infusion of recombinant interleukin-2 in sheepF L Glauser, G G DeBlois, D E Bechard, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|March 1, 1988
Cardiopulmonary effects of recombinant interleukin-2 infusion in sheepF L Glauser, G G DeBlois, D E Bechard, et al.
Archives of Pathology & Laboratory Medicine|May 16, 2012
Validation of interobserver agreement in lung cancer assessment: hematoxylin-eosin diagnostic reproducibility for non-small cell lung cancer: the 2004 World Health Organization classification and therapeutically relevant subsetsJuneko E Grilley-Olson, D Neil Hayes, Dominic T Moore, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Cancer Research|April 15, 1988
A comparison of the cardiopulmonary effects of continuous versus bolus infusion of recombinant interleukin-2 in sheepF L Glauser, G G DeBlois, D E Bechard, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|March 1, 1988
Cardiopulmonary effects of recombinant interleukin-2 infusion in sheepF L Glauser, G G DeBlois, D E Bechard, et al.
Archives of Pathology & Laboratory Medicine|May 16, 2012
Validation of interobserver agreement in lung cancer assessment: hematoxylin-eosin diagnostic reproducibility for non-small cell lung cancer: the 2004 World Health Organization classification and therapeutically relevant subsetsJuneko E Grilley-Olson, D Neil Hayes, Dominic T Moore, et al.
Pageof 3